Super Religare Laboratories Ltd. (a Subsidiary of Fortis Healthcare) has secured a PE funding for Rs. 370 Cr. from International Finance Corporation (IFC) and NYLIM Jacob Ballas India fund. IFC , a World Bank investment arm would be investing Rs. 250 Cr. , while NYLIM Jacon Ballas India fund would be investing Rs. 120 Cr.…
about people, work, and workplaces